These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22409864)

  • 1. Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.
    Gangireddy Vg; Liles GB; Sostre GD; Coleman T
    Clin Genitourin Cancer; 2012 Jun; 10(2):134-9. PubMed ID: 22409864
    [No Abstract]   [Full Text] [Related]  

  • 2. Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
    Tlemcani K; Levine D; Smith RV; Brandwein-Gensler M; Staffenberg DA; Garg MK; Shifteh K; Haigentz M
    J Clin Oncol; 2010 Aug; 28(24):e412-4. PubMed ID: 20406935
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged survival of a patient with sickle cell trait and metastatic renal medullary carcinoma.
    Pirich LM; Chou P; Walterhouse DO
    J Pediatr Hematol Oncol; 1999; 21(1):67-9. PubMed ID: 10029817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.
    Kosmidis PA; Syrigos K; Kalofonos HP; Dimopoulos MA; Skarlos D; Pavlidis N; Boukovinas I; Bafaloukos D; Pectasides D; Bacoyiannis C; Fountzilas G
    Anticancer Res; 2012 Jan; 32(1):175-81. PubMed ID: 22213304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.
    Lalisang RI; Erdkamp FL; Rodenburg CJ; Knibbeler-van Rossum CT; Nortier JW; van Bochove A; Slee PH; Voest EE; Wils JA; Wals J; Loosveld OJ; Smals AE; Blijham GH; Tjan-Heijnen VC; Schouten HC
    Breast Cancer Res Treat; 2011 Jul; 128(2):437-45. PubMed ID: 21584666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal medullary carcinoma: case report and review of the literature.
    Noguera-Irizarry WG; Hibshoosh H; Papadopoulos KP
    Am J Clin Oncol; 2003 Oct; 26(5):489-92. PubMed ID: 14528077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastasis of medullar thyroid carcinoma (case report)].
    Moutaouakil A; Baha AT; Amraoui A
    Bull Soc Belge Ophtalmol; 2003; (288):19-22. PubMed ID: 12879721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of outcomes of Taxol + Cisplatin and Taxol + Nedaplatin chemotherapy regimens for advanced non-small cell lung cancer].
    Cai YP; Xu S; Lin SJ
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):74-5. PubMed ID: 20211076
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal medullary carcinoma and sickle cell trait.
    Friedrichs P; Lassen P; Canby E; Graham C
    J Urol; 1997 Apr; 157(4):1349. PubMed ID: 9120938
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.
    Walsh A; Kelly DR; Vaid YN; Hilliard LM; Friedman GK
    Pediatr Blood Cancer; 2010 Dec; 55(6):1217-20. PubMed ID: 20979179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
    Loibl S; Murmann C; Schwedler K; Warm M; Müller L; Heinrich G; Nekljudova V; von Minckwitz G
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):953-8. PubMed ID: 18716777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal medullary carcinoma: an aggressive neoplasm in patients with sickle cell trait.
    Pickhardt PJ
    Abdom Imaging; 1998; 23(5):531-2. PubMed ID: 9841069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.
    Bell MD
    Pediatr Blood Cancer; 2006 Aug; 47(2):228. PubMed ID: 16514612
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal medullary carcinoma, a rare cause of haematuria in sickle cell trait.
    Patel K; Livni N; Macdonald D
    Br J Haematol; 2006 Jan; 132(1):1. PubMed ID: 16371012
    [No Abstract]   [Full Text] [Related]  

  • 16. Cystic presentation of a renal medullary carcinoma in a young woman.
    Levi Sandri GB; Spoletini G; Lai Q; Mennini G; Rossi M
    Urologia; 2015; 82(2):124-6. PubMed ID: 25451881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastasis as the presenting complaint in ovarian carcinoma.
    Kingston R; Sparkes J; Leen E; Stafford-Johnson D; Keogh P
    Acta Obstet Gynecol Scand; 2001 Jul; 80(7):669-70. PubMed ID: 11437731
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radiotherapy in treatment of relapsing renal cell cancer].
    Metelev VV; Zharinov GM
    Vopr Onkol; 2008; 54(6):775-7. PubMed ID: 19241859
    [No Abstract]   [Full Text] [Related]  

  • 19. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report.
    Lee JS; Pisters KM; Komaki R; Glisson BS; Khuri FR; Schea R; Fossella FV
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-52-S12-55. PubMed ID: 9331122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of progressive gastric carcinoma accompanied by disseminated carcinomatosis of bone marrow due to bone metastasis with DIC recovery by joint administration of 5-FU and paclitaxel].
    Satoh D; Ninomiya M; Umeoka T; Harano M; Sasaki H; Aoki H; Onoda T; Shiozaki Y; Ohno S; Higaki K; Takakura N
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2079-81. PubMed ID: 17197758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.